SCIENTIFIC HUB

Follow the evidence.

185.253 articles found

Open access

Tear fluid as a novel specimen for detection of alpha-synuclein seeding activity in Parkinson's disease.

Costanzo M, Ladogana A, Sbriccoli M, Marchet F, Porreca F, Salciccia C, Equestre M, Moracci G, De Bartolo MI, Ruocco G, Carlà FC, Conte A, Fabbrini G, Belvisi D, Poleggi A.

Sci Rep · 2026-04-10

DOI: 10.1038/s41598-026-48093-2PMID: 41963524

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Nanostructured Lipid Carriers Enhance Brain Delivery and Antioxidant Efficacy of a Small-Molecule MAO B Inhibitor for Neurodegenerative Disease Therapy.

Mastrogiacomo R, Miniero DV, Rullo M, Rizzi F, Minervini G, Panniello A, Striccoli M, Fanizza E, Comparelli R, Curri ML, Catto M, Liuzzi GM, Pisani L, Latronico T, Depalo N.

Mol Pharm · 2026-04-10

DOI: 10.1021/acs.molpharmaceut.5c01754PMID: 41962139

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Distinct metabolic signatures of Alzheimer's and Parkinson's disease revealed through genetic overlap.

Stinson SE, Shadrin AA, Rahman Z, Rødevand L, Broce IJ, Selbæk G, Stefansson H, Haavik J, Parker N, Koch E, Frei O, O'Connell KS, Smeland OB, Djurovic S, Dale AM, van der Meer D, Andreassen OA.

EBioMedicine · 2026-04-10

DOI: 10.1016/j.ebiom.2026.106254PMID: 41966729

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Effects of an 8-Week Combined Aerobic-Resistance Training on Motor Function, Functional Mobility, and Metabolic Parameters in Patients with Parkinson's Disease: A Controlled Study.

Janovič Š, Szabo E, Gábor M, Straka I, Majerníková Z, Kušnírová A, Boleková V, Košutzká Z.

NeuroRehabilitation · 2026-04-10

DOI: 10.1177/10538135261434253PMID: 41960943

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Optimized reference region and the effect on test-retest reliability and sensitivity to differences between Parkinson's disease and control groups with [<sup>11</sup>C]UCB-J.

Khattar N, Matuskey D, Gallezot JD, Naganawa M, Holmes SE, Ebrahimian Sadabad F, Mayeli M, Esterlis I, van Dyck CH, Mecca AP, D'Souza DC, Nabulsi NB, Finnema SJ, Huang Y, Carson RE, Toyonaga T.

J Cereb Blood Flow Metab · 2026-04-10

DOI: 10.1177/0271678x261441071PMID: 41960765

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.